BDBM752653 1,8-dimethyl-3-(1- methylcyclopropyl)-5-[[(1R)-1-[3- (1,1-difluoro-2-hydroxy-2-methyl- propyl)phenyl]ethyl]amino]imidazo [4,5-g]phthalazin-2-one::US20250197407, Compound 83

SMILES Cc1nnc(N[C@H](C)c2cccc(C(F)(F)C(C)(C)O)c2)c2cc3c(cc12)n(C)c(=O)n3C1(C)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752653   

TargetKRas/Son of Sevenless Homolog 1(Human)
Jazz Pharmaceuticals Ireland

US Patent
LigandPNGBDBM752653(1,8-dimethyl-3-(1- methylcyclopropyl)-5-[[(1R)-1-[...)
Affinity DataIC50: 7.94nMAssay Description:The capacity of compounds to inhibit SOS1 binding to KRAS-WT (wild-type) was quantified using a FRET-based protein-protein interaction assay. The ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent